Journal article
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
Abstract
BackgroundA precision medicine approach in type 2 diabetes requires the identification of clinical and biological features that are reproducibly associated with differences in clinical outcomes with specific anti-hyperglycaemic therapies. Robust evidence of such treatment effect heterogeneity could support more individualized clinical decisions on optimal type 2 diabetes therapy.MethodsWe performed a pre-registered systematic review of …
Authors
Young KG; McInnes EH; Massey RJ; Kahkoska AR; Pilla SJ; Raghavan S; Stanislawski MA; Tobias DK; McGovern AP; Dawed AY
Journal
Communications Medicine, Vol. 3, No. 1,
Publisher
Springer Nature
DOI
10.1038/s43856-023-00359-w
ISSN
2730-664X